FIELD: pharmacology.
SUBSTANCE: pharmaceutical composition for prevention or treatment of a disease associated with 15-lipoxygenase, comprising a therapeutically effective amount of a compound of 3-[4-(3,4-dimethoxyphenyl)-piperazine-1-yl]-3-oxo-1-phenylpropyl ester of (R) carbamic acid. The invention also relates to a method for treatment of a disease associated with 15-lipoxygenase, as well as a pharmaceutical composition with inhibitory activity.
EFFECT: implementation of the invention allows to increase the effectiveness of prevention or treatment of diseases associated with 15-lipoxygenase, such as diabetic nephropathy, diabetic neuropathy, vascular complications of diabetes, hyperlipidemia and inflammatory reactions induced by diabetes.
3 cl, 15 ex, 2 tbl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
CARBAMOYLOXYARYL ALKANOYL ARYLPIPERAZINE COMPOUND, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUND AND METHOD OF TREATING PAIN, ANXIETY AND DEPRESSION | 2008 |
|
RU2460731C2 |
PYRAZOLE-AMIDE COMPOUND AND MEDICINAL USES THEREFOR | 2014 |
|
RU2664532C2 |
PYRIDYLOXY DERIVATIVES EFFECTIVE AS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA ACTIVATOR/MODULATOR | 2010 |
|
RU2480463C1 |
USE OF SIGMA LIGANDS IN DIABETES TYPE-2 ASSOCIATED PAIN | 2012 |
|
RU2608943C2 |
COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | 2006 |
|
RU2420276C2 |
BENZENE OR THIOPHEN DERIVATIVE AND USING IT AS VAP-1 INHIBITOR | 2009 |
|
RU2526256C2 |
2-PROPEN-1-ONS AS HSP-70 INDUCTORS | 2005 |
|
RU2341522C2 |
SPIROCHROMANONE DERIVATIVES AS ACETYL COENZYME A CARBOXYLASE (ACC) INHIBITORS | 2006 |
|
RU2422446C2 |
THIAZOL DERIVATIVE AND USING IT AS VAP-1 INHIBITOR | 2009 |
|
RU2496776C9 |
PYRIDINE DERIVATIVES FOR TREATING METABOLIC DISORDERS ASSOCIATED WITH INSULIN RESISTANCE OR HYPERGLYCAEMIA | 2007 |
|
RU2448093C2 |
Authors
Dates
2017-09-11—Published
2011-07-08—Filed